Medication Management for Severe Anxiety with Panic
For severe anxiety with panic disorder, selective serotonin reuptake inhibitors (SSRIs) such as sertraline are recommended as first-line pharmacotherapy, with benzodiazepines like alprazolam reserved for short-term adjunctive use only. 1, 2, 3
First-Line Pharmacological Treatment
SSRIs/SNRIs
Sertraline is FDA-approved for panic disorder and has demonstrated efficacy in both short and long-term studies 2, 4
- Starting dose: 25-50 mg daily
- Target dose: 50-200 mg daily
- Benefits: Reduces severity and frequency of panic attacks, baseline anxiety, and provides protection from relapse 4
Alternative first-line options:
Important Considerations for SSRI/SNRI Therapy
- Therapeutic effect typically takes 4-6 weeks to fully develop
- Initial anxiety exacerbation may occur in first 1-2 weeks
- Continue treatment for at least 6-12 months after symptom remission
- Gradual tapering essential when discontinuing to avoid withdrawal symptoms 1
Short-Term Adjunctive Treatment
Benzodiazepines
- Alprazolam: FDA-approved for panic disorder 3
Treatment Algorithm
Initial Treatment:
- Start with SSRI (sertraline 25-50 mg daily, titrate up as needed)
- Consider short-term benzodiazepine (alprazolam) only during first 2-4 weeks while waiting for SSRI effect
After 4-6 weeks:
- Assess response to SSRI
- If inadequate response: Increase SSRI dose or switch to another SSRI/SNRI
For treatment-resistant cases:
- Consider augmentation with non-benzodiazepine anxiolytics like buspirone
- Consider referral to psychiatry for specialized care
Non-Pharmacological Interventions
Cognitive Behavioral Therapy (CBT)
- Structured treatment consisting of approximately 14 sessions over 4 months
- Individual sessions lasting 60-90 minutes 6, 1
- Components should include:
- Psychoeducation
- Cognitive restructuring
- Gradual exposure to feared situations
- Relapse prevention
Lifestyle Modifications
- Establish consistent morning routine
- Regular exercise, particularly in morning
- Good sleep hygiene
- Limit screen time before bed
- Practice mindfulness and meditation 1
Monitoring and Evaluation
- Assess response to treatment after 4-6 weeks
- Monitor for side effects, particularly during initial treatment phase
- For moderate to severe functional impairment, combination of CBT and SSRI/SNRI provides optimal outcomes 1, 7
- Consider tapering medications if symptoms are well-controlled for 6-12 months
Cautions and Pitfalls
- Avoid long-term benzodiazepine use due to tolerance, dependence, and cognitive effects 5
- Be aware of potential initial anxiety exacerbation with SSRIs
- SSRIs require consistent daily dosing and cannot be used "as needed"
- Abrupt discontinuation of either SSRIs or benzodiazepines can cause withdrawal symptoms
- Special populations (elderly, hepatic/renal impairment) require dose adjustments 1
The evidence consistently supports SSRIs as first-line treatment for panic disorder, with meta-analyses showing small to medium effect sizes compared to placebo 7. While benzodiazepines provide rapid relief, their use should be limited to short-term adjunctive therapy due to dependence risks 1, 5.